← Browse by Condition
Medical Condition
aml
Total Trials
6
Recruiting Now
6
Trial Phases
Phase 1, Phase 2, Phase 1
NCT06131801
Recruiting
Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
Enrollment
30 pts
Location
United States
Sponsor
Children's Hospital Medical Ce...
NCT06386302
Recruiting
Chidamide, Venetoclax, and Azacitidine for Newly Diagnosed Acute Myeloid Leukemia
Enrollment
184 pts
Location
China
Sponsor
Institute of Hematology & Bloo...
NCT06611839 Phase 1, Phase 2
Recruiting
Venetoclax in Combination With Ivosidenib and Azacitidine for Newly Diagnosed IDH1-Mutated AML
Enrollment
29 pts
Location
China
Sponsor
Institute of Hematology & Bloo...
NCT03050268
Recruiting
Familial Investigations of Childhood Cancer Predisposition
Enrollment
1,500 pts
Location
United States
Sponsor
St. Jude Children's Research H...
NCT05287568 Phase 1
Recruiting
CC-486 and Venetoclax for Acute Myeloid Leukemia
Enrollment
35 pts
Location
United States
Sponsor
University of Colorado, Denver
NCT04686682 Phase 1, Phase 2
Recruiting
A First-in-Human, JAB-8263 in Adult Patients With Advanced Tumors
Enrollment
152 pts
Location
China
Sponsor
Jacobio Pharmaceuticals Co., L...